Introduction
Favipiravir 400mg is an oral antiviral drug that selectively inhibits viral replication, particularly of RNA viruses. It was first developed for influenza but has been repurposed for several viral infections, including SARS-CoV-2. Its unique mechanism makes it effective against a wide range of RNA viruses.
Mechanism of Action
Favipiravir acts as a prodrug that, once inside the host cells, converts into its active form, favipiravir ribofuranosyl-5′-triphosphate (favipiravir-RTP). This active metabolite selectively inhibits the RNA-dependent RNA polymerase (RdRp) enzyme of the virus, an essential enzyme for viral RNA replication. By mimicking purine nucleosides, favipiravir-RTP either causes premature termination of viral RNA synthesis or induces lethal mutagenesis, resulting in nonviable or defective viral progeny. This mechanism distinguishes it from other antiviral drugs that typically prevent viral entry or release.
Favipiravir 400mg Uses:
Tab Favipiravir 400mg is primarily indicated for:
Treatment of influenza virus infections
Management of COVID-19 in mild to moderate cases
Potential treatment against other RNA viruses such as arenaviruses and bunyaviruses
It is used to reduce viral load and symptom severity by inhibiting viral replication.
Efficacy and Clinical Evidence
Clinical trials have demonstrated that favipiravir improves clinical recovery rates and accelerates viral RNA clearance in patients with COVID-19 and influenza. Studies using animal models and human subjects validate its antiviral activity and safety profile. Its broad-spectrum efficacy is attributed to the conserved nature of the RdRp enzyme across RNA viruses.
Side Effects and Safety Profile
Common side effects of favipiravir include:
Elevated liver enzymes
Gastrointestinal discomfort (nausea, diarrhea)
Hyperuricemia (increased uric acid levels)
Mild to moderate skin rashes
It is generally well tolerated, but monitoring liver function and uric acid levels during treatment is advised.
Contraindications and Precautions
Favipiravir is contraindicated in:
Pregnant women due to potential teratogenic effects
Patients with severe hepatic or renal impairment (use caution)
Precautions include avoiding use in breastfeeding mothers and careful consideration in patients with gout or hyperuricemia.
Drug Interactions
Favipiravir may interact with drugs that affect liver enzymes and drugs causing hyperuricemia. Co-administration with other antiviral agents should be done carefully, with medical supervision to avoid additive toxicity or reduced efficacy.
Warnings and Regulatory Status
Favipiravir has been approved for emergency or conditional use in many countries for the treatment of COVID-19 and influenza. Regular monitoring for adverse effects is recommended during therapy. Regulatory approvals vary by region but emphasize its role in managing viral infections where alternative treatments are limited.
Patient Advice and Tips
Take favipiravir 400mg tablet exactly as prescribed by your healthcare provider.
Complete the full course even if symptoms improve.
Avoid pregnancy during and several months after treatment.
Inform your doctor of any other medications you are taking.
Report any unusual side effects immediately.
Availability
Favipiravir 400mg tablets are widely available under various brand names, including from pharmaceutical companies like Steris Healthcare Pvt Ltd, known for quality manufacturing standards.
Frequently Asked Questions
What is favipiravir 400mg used for?
It is used to treat viral infections like influenza and COVID-19 by inhibiting viral RNA replication.How does favipiravir work?
It inhibits the viral RNA polymerase enzyme, thereby stopping viral replication.Are there side effects?
Yes, including nausea, liver enzyme changes, and potential hyperuricemia.Can pregnant women take favipiravir?
No, it is contraindicated in pregnancy due to teratogenic risk.Is favipiravir effective against COVID-19?
Clinical evidence supports its efficacy in improving recovery and clearing viral RNA in mild to moderate COVID-19 cases.
Why Choose Steris Healthcare Pvt Ltd?
Steris Healthcare Pvt Ltd is a trusted manufacturer known for:
High-quality pharmaceutical production complying with Good Manufacturing Practices (GMP)
Ensuring consistent potency and purity of favipiravir 400mg tablets
Reliable supply chain management and customer support
Commitment to affordable and accessible healthcare solutions
Conclusion
Favipiravir 400mg is a potent antiviral agent with proven efficacy against influenza and COVID-19, acting through selective inhibition of viral RNA polymerase. Its favorable safety profile and broad antiviral activity make it a valuable therapeutic option. Manufactured by reputed companies like Steris Healthcare Pvt Ltd, it ensures quality and accessibility for patients in need of effective antiviral treatment.
